
浏览全部资源
扫码关注微信
纸质出版日期:2012
移动端阅览
刘雪梅, 谭正怀, 王莉, 等. 绞股蓝与黄芩防治糖尿病心脏病的协同作用研究[J]. 中国实验方剂学杂志, 2012,18(24):295-300.
LIU Xue-mei, TAN Zheng-huai, WANG Li, et al. Study on the Synergistic Effect between and in Control of Diabetic Cardiopathy[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(24): 295-300.
目的: 探讨绞股蓝与黄芩在防治糖尿病心脏病方面可能存在的协同作用及相关机制。 方法: 体外考察绞股蓝提取物(GP)
黄芩提取物(SBG)
以及绞股蓝提取物与黄芩提取物的混合物(GPSBG)各0.5
5
50 mg·L-1对血管内皮细胞、心肌细胞以及系膜细胞的直接作用;采用高脂大鼠加静脉注射链脲佐菌素(STZ)25 mg·kg-1诱导糖尿病心脏病大鼠模型
将造型成功的动物随机分为GP 300 mg·kg-1
SBG 300 mg·kg-1
GPSBG 600 mg·kg-1以及模型组
每天灌胃给药1次
连续8周
末次给药后24 h测定各心脏血流动力学相关指标
并取血测定血脂。 结果: SBG 5 mg·L-1可对抗高糖抑制血管内皮细胞ECV-304生长(P<0.05)、增加一氧化氮(NO)生成(P<0.05)
抑制系膜细胞增殖(P<0.001);GPSBG 5 mg·L-1可对抗高糖抑制ECV-304生长(P<0.05)、增加一氧化氮(NO)生成(P<0.001)、降低谷胱甘肽(GSH)水平(P<0.001)的作用
抑制系膜细胞增殖(P<0.001);GP 5 mg·L-1可对抗H2O2抑制心肌细胞生长(P<0.05)、增加NO生成(P<0.05)、降低GSH水平(P<0.05)的作用;SBG 0.5 mg·L-1可以减少H2O2环境下心肌细胞的NO生成(P<0.05)
提高GSH(P<0.05)水平;GPSBG 5 mg·L-1均可对抗H2O2抑制心肌细胞生长(P<0.05)、增加NO生成(P<0.05)、降低GSH水平(P<0.001)的作用;GP 300 mg·kg-1
SBG 300 mg·kg-1可抑制Ⅱ型糖尿病大鼠心脏指数的增加(P<0.05)
GPSBG 600 mg·kg-1则可显著降低Ⅱ型糖尿病大鼠血清甘油三酯(TG)、总胆固醇(TC)水平以及心脏指数(P<0.05或P<0.001)
GP 300 mg·kg-1可显著增加Ⅱ型糖尿病大鼠心率、左室收缩压、左室舒张末期压、左室收缩及舒张时间变化率等指标
降低左室舒张末期压(P<0.05);SBG 300 mg·kg-1可显著降低Ⅱ型糖尿病大鼠左室舒张末期压(P<0.05);GPSBG 600 mg·kg-1可显著增加Ⅱ型糖尿病大鼠心率、左室收缩压、左室收缩及舒张时间变化率
降低左室舒张末期压(P<0.01或P<0.001)。 结论: 上述研究结果显示:GP
SBG在改善Ⅱ型糖尿病大鼠心脏功能方面表现出明显的协同增效作用
这可能与黄芩、绞股蓝均有降低Ⅱ型糖尿病大鼠血清TG
TC水平的趋势
并能在内皮细胞、心肌细胞、系膜细胞以及醛糖还原酶等方面作用有关。
Objective:To study the synergistic effect between Gynostemma pentaphyllum (GP) and Scutellaria baicalensis Georgi (SBG) in control of diabetic cardiopathy(DC)
providing the scientific basis for the clinical application. Method: The in vitro effects of GP (0.5
5
50 mg·L-1)
SBG (0.5
5
50 mg·L-1) and the mixture of GP extract and SBG extract (GPSBG
0.5
5
50 mg·L-1) on vascular endothelial cells
myocardial cells and mesangial cells were investigated. Rat model of DC was induced by high fat feeding and injection of streptozotocin(STZ)of 25 mg·kg-1. The DC rats were randomly divided into GP 300 mg·kg-1
SBG 300 mg·kg-1
GPSBG 600 mg·kg-1 and DC model group. The investigation groups were respectively ig given corresponding extracts once daily for 8 weeks
while the controls and the models were given the same volume of sodium carboxy methyl cellulose (0.5%). The cardiac hemodynamic indexes and serum lipids were measured at 24 hours after the last administration. Result: SBG 5 mg·L-1and GPSBG 5 mg·L-1could compete the suppression of ECV-304 growth in 30 mmol·L-1 glucose
increasing NO generation
reduce GSH levels
compete the inhibition of mesangial cell proliferation in 30 mmol·L-1 glucose medium. SBG 5 mg·L-1
GP 5 mg·L-1 and GPSBG 5 mg·L-1could compete the suppression of ECV-304 growth
increase NO generation
reduce GSH levels by H2O2 on myocardial cell. GP 300 mg·kg-1and SBG 300 mg·kg-1 could decrease the cardiac index in typeⅡdiabetic rats
GPSBG 600 mg·kg-1 could significantly reduce the serum levels of TG and TC
index of heart in typeⅡdiabetic rats. GP 300 mg·kg-1 could significantly increase left ventricular systolic blood pressure and heart rate
left ventricular end-diastolic pressure
the rate index of left ventricular contraction and relaxation time
and lower left ventricular end-diastolic pressure. SBG 300 mg·kg-1could significantly reduce left ventricular end-diastolic pressure
GPSBG 600 mg·kg-1 could significantly increase heart rate
left ventricular systolic blood pressure
left ventricular contraction and relaxation time rate
reduce left ventricular end-diastolic pressure in typeⅡdiabetic rats. Conclusion: GP and SBG show synergistic effect on improving cardiac function in typeⅡdiabetic rats. This may be related to the effects of GP and SBG on reducing serum TG
TC in typeⅡ diabetic rats
and their effects on endothelial cells
myocardial cells
mesangium cells and aldose reductase.
0
浏览量
7
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621